Pasternak B, Wintzell V, Hviid A, et al
Tirzepatide, meanwhile, combines the effects of both GLP-1 and GIP receptor agonists, offering dual action that may further enhance appetite suppression and metabolic benefits
4.1 Revisiting classical pathways: context-dependent roles of Nrf2 and HDAC inhibition SFN activates the Nrf2 pathway through covalent modification of specific cysteine residues (Cys151, Cys273, and Cys288) on the Keap1 protein, leading to Nrf2 stabilization, nuclear translocation, and transcriptional activation of cytoprotective genes including NAD(P)H quinone oxidoreductase 1 (NQO1), heme oxygenase-1 (HO-1), and glutathione biosynthesis enzymes (63)
Long-acting GLP-1 agonists may be of greatest benefit in patients who require specific control of fasting hyperglycemia (Guo 2016
Hence, patients with MCAS often go undiagnosed and continue to experience episodes whenever theyre exposed to a trigger that has yet to be identified
These effects contribute to renal protection and may improve cardiac function in T2D patients with cardiovascular risk